Topic: Squalene

Researchers at the University of Bergen in Norway discovered that polar bear fur remains ice-free due to a specific type of grease that lacks squalene. This natural "goop" performs as well as synthetic PFAS chemicals used in ski waxes and industrial lubricants. The study suggests that the chemical structure of polar bear hair grease could lead to the development of greener de-icing fluids for commercial aircraft.

Professor David Salisbury, director of the UK immunization program, explains the use of adjuvants in H1N1 vaccines to boost immune response with smaller doses. He describes the ingredients as natural, including Vitamin E and fish oil (squalene). The hosts express skepticism regarding the lack of stringent FDA testing and the absence of placebo-controlled studies for these vaccines.

Speculation arises that the vicious flu outbreak in the Ukraine may be a mutated strain of H1N1. The hosts suggest that this "hemorrhagic" version of the virus will be used as a justification to add squalene or other adjuvants to vaccines globally. They predict a surge in donations if these stronger vaccine components are mandated.

Discrepancies on the flu.gov website regarding the use of squalene adjuvants in H1N1 vaccines are highlighted. While the US government claims no adjuvants are "currently" used, the hosts suggest they are being phased in. Reports from Sweden are cited, alleging that several people have died or become seriously ill shortly after receiving the swine flu vaccination, though the hosts admit the machine translations of Swedish news are crude.

The use of squalene in vaccine adjuvants has a controversial history linked to military testing and Gulf War Syndrome. Research into these emulsion vehicles began at Fort Detrick in 1987, and the military has a history of administering experimental shots to service members without detailed record-keeping. These same compounds are now being integrated into public swine flu vaccines under various commercial names.